Olema Pharmaceuticals Inc (OLMA)

SG&A Expense Growth

8.79%

Quarterly · Period ending:

OLMA logo

OLMA SG&A Expense Growth

Latest reported8.79%
OLMA Quarterly SG&A Growth (QoQ) (0.00% → 8.79%)
High-resolution chart · PNG

OLMA sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Olema Pharmaceuticals Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
8.7898%
25.8013%
15.8286%
49.5709%
-6.7545%
-4.9228%
1.6837%
-0.5881%
-0.7855%
-1.9366%
16.8424%
7.6689%
-46.6942%
20.2484%
0.7149%
-10.3222%
-13.8854%
25.3027%
10.3646%
13.595%
-3.0685%
23.8417%
20.2504%
492.7644%
117.3387%
131.7757%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.